CDK2-IN-21

• Description:

  CDK2-IN-21 (example 30) is a potent cyclin-dependent kinase 2 (CDK2) inhibitor with an IC50 of 0.24 µM. CDK2-IN-21 can be used for cancer research[1].

• UNSPSC:

  12352005

• Target:

  CDK

• Related Pathways:

  Cell Cycle/DNA Damage

• Applications:

  Cancer-Kinase/protease

• Field of Research:

  Cancer

• Smiles:

  FC (F) (C12CC (C2) (C3=NC (C4=C (C (NS (=O) (C5=C (C=CC=C5F) C (F) (F) F) =O) =CC=C4) F) =C (C6=NC (N[C@@H]7CC[C@H] (CC7) S (C) (=O) =O) =NC=C6) S3) C1) F

• Molecular Formula:

  C33H29F8N5O4S3

• Molecular Weight:

  807.80

• References & Citations:

  [1]Yan Lou. Sulfonamido derivatives as cyclin-dependent kinase 2 inhibitors. US20230303509. 2025-06-17.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• Isoform:

  CDK2

• CAS Number:

  2991229-06-0